Pietro Fratta Selected Research

Type 4E Charcot-Marie-Tooth disease

5/2019	Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.
1/2019	Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.
1/2019	Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Fratta Research Topics

Disease

28	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 06/2010
10	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 01/2014
10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 08/2013
6	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 06/2010
5	Muscular Atrophy (Muscle Atrophy) 01/2022 - 05/2013
4	Disease Progression 10/2020 - 05/2015
3	Neuromuscular Diseases (Neuromuscular Disease) 01/2022 - 01/2015
3	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 05/2013
3	Type 4E Charcot-Marie-Tooth disease 05/2019 - 01/2019
2	Muscle Weakness 01/2022 - 10/2020
2	X-Linked Bulbo-Spinal Atrophy 10/2020 - 12/2019
2	Inclusion Body Myositis 06/2014 - 08/2005
2	Motor Neuron Disease (Primary Lateral Sclerosis) 02/2014 - 08/2013
1	Hypertrophy 01/2022
1	Atrophy 01/2022
1	Neoplasms (Cancer) 10/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2020
1	Dementia (Dementias) 11/2020
1	Prodromal Symptoms 10/2020
1	Tremor (Tremors) 10/2020
1	Bilateral Vestibulopathy 01/2019
1	Ataxia (Dyssynergia) 01/2019
1	Fragile X Syndrome (Martin Bell Syndrome) 06/2015
1	Intellectual Disability (Idiocy) 06/2015
1	Myotonia 12/2014
1	Paralysis (Palsy) 12/2014
1	Channelopathies 12/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2011
1	Neuroinflammatory Diseases 08/2011
1	Proteostasis Deficiencies 06/2010
1	Demyelinating Diseases (Demyelinating Disease) 02/2006

Drug/Important Bio-Agent (IBA)

9	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 10/2021 - 06/2010
8	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2014
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2015
4	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 06/2010
4	Androgen Receptors (Androgen Receptor)IBA 10/2020 - 05/2013
3	Neuregulin-1 (Neuregulin 1)IBA 05/2019 - 01/2019
2	polyglutamineIBA 01/2022 - 05/2013
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022 - 12/2019
2	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2022 - 10/2021
2	RibonucleoproteinsIBA 01/2022 - 06/2014
2	CreatinineIBA 10/2020 - 12/2019
2	RNA-Binding Protein FUSIBA 01/2020 - 05/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2014
2	Superoxide Dismutase-1IBA 04/2015 - 08/2013
2	Mutant Proteins (Protein, Mutant)IBA 08/2013 - 02/2006
1	Ferritins (Ferritin)IBA 01/2022
1	ChromatinIBA 01/2022
1	chitotriosidaseIBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	AntibodiesIBA 01/2021
1	DipeptidesIBA 01/2021
1	Replication Protein C (Replication Factor C)IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 06/2015
1	AutoantibodiesIBA 05/2015
1	Indicators and Reagents (Reagents)IBA 05/2015
1	NAV1.4 Voltage-Gated Sodium ChannelIBA 12/2014
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 12/2014
1	Antisense RNA (Anti-Sense RNA)IBA 12/2013
1	EnzymesIBA 08/2013
1	Nerve Growth Factors (Neurotrophins)IBA 08/2011
1	Cellular Apoptosis Susceptibility ProteinIBA 06/2010
1	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 08/2005
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2005

Therapy/Procedure

4	Therapeutics 11/2020 - 08/2013
2	Denervation 01/2022 - 10/2021
1	Precision Medicine 01/2019